Research Studies

SYSTEM-WIDE, HUNDREDS OF RESEARCH STUDIES ARE TYPICALLY IN PROGRESS OR UNDER REVIEW AT ANY GIVEN TIME.  THE IMPORTANCE OF RESEARCH TO McLAREN HEALTH CARE CANNOT BE OVERSTATED.

The newest component of our research portfolio - the Clinical Cancer Research Center, a collaboration of Michigan State University's college of Human Medicine and Karmanos Cancer Institute. This partnership brings leading-edge clinical trials to patients in communities served by McLaren subsidiary hospitals and the Karmanos Cancer Institute facilities.

Over the past decade, McLaren Health Care has carefully and conscientiously developed one of the largest multidisciplinary research programs in the state. We are working with many of the leading names in the international medical/pharmaceutical and general health care industries, as well as universities, foundations, agencies, and others on important, life-enhancing work.

Research work undertaken through McLaren Health Care subsidiaries typically falls into one of four categories: resident research, faculty research, nurse research or clinical trial research. All research programs administered through McLaren Health Care adhere to Food and Drug Administration and NSA Standards of Good Practice.

Resident research relates to the programs instituted by medical residents in the system's graduate medical education program. These programs introduce the young medical professionals to the world of research with oversight and assistance coordinated through specialists within the system.

Approximately one-third of all research undertaken by the McLaren system is related to cancer. Oncology has been an extremely strong discipline for McLaren Health Care. Through our Karmanos Cancer Institute, literally thousands of clinical trials and studies have been undertaken over the past five years alone